News of cardiology and cardiac surgery

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. A Report of the American College of Cardiology / American Heart Association Joint Committee on Clinical Practice Guidelines

J.S. Lawton, J.E. Tamis-Holland, S. Bangalore, E.R. Bates, T.M. Beckie,J.M. Bischoff, J.A. Bittl, M.G. Cohen, J.M. DiMaio, C.W. Don, S.E. Fremes, M.F. Gaudino, Z.D. Goldberger, M.C. Grant, J.B. Jaswal, P.A. Kurlansky, R. Mehran, T.S. Metkus Jr, L.C. Nnacheta, S.V. Rao, F.W. Sellke, G. Sharma, C.M. Yong, B.A. Zwischenberger

 Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients’ interests.

Key words: coronary artery disease, myocardial revascularization.